相似文献
1
The Role of the Osteocyte in Bone and Nonbone Disease.
Endocrinol Metab Clin North Am. 2017 Mar;46(1):1-18. doi: 10.1016/j.ecl.2016.09.003. Epub 2016 Dec 12.
2
The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases.
Front Endocrinol (Lausanne). 2020 Jul 8;11:405. doi: 10.3389/fendo.2020.00405. eCollection 2020.
3
A Novel Osteogenic Cell Line That Differentiates Into GFP-Tagged Osteocytes and Forms Mineral With a Bone-Like Lacunocanalicular Structure.
J Bone Miner Res. 2019 Jun;34(6):979-995. doi: 10.1002/jbmr.3720. Epub 2019 Jun 7.
4
Importance of osteocyte-mediated regulation of bone remodelling in inflammatory bone disease.
Swiss Med Wkly. 2020 Feb 7;150:w20187. doi: 10.4414/smw.2020.20187. eCollection 2020 Jan 27.
5
The osteocyte: A multifunctional cell within the bone.
Ann Anat. 2020 Jan;227:151422. doi: 10.1016/j.aanat.2019.151422. Epub 2019 Sep 26.
6
The amazing osteocyte.
J Bone Miner Res. 2011 Feb;26(2):229-38. doi: 10.1002/jbmr.320.
7
Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
Biofactors. 2014 Nov-Dec;40(6):555-68. doi: 10.1002/biof.1186. Epub 2014 Oct 29.
8
Human primary osteocyte differentiation in a 3D culture system.
J Bone Miner Res. 2009 Nov;24(11):1927-35. doi: 10.1359/jbmr.090517.
9
Architecture of the osteocyte network correlates with bone material quality.
J Bone Miner Res. 2013 Aug;28(8):1837-45. doi: 10.1002/jbmr.1927.
10
The osteocyte as a signaling cell.
Physiol Rev. 2022 Jan 1;102(1):379-410. doi: 10.1152/physrev.00043.2020. Epub 2021 Aug 2.
引用本文的文献
1
X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells.
Calcif Tissue Int. 2025 Sep 9;116(1):120. doi: 10.1007/s00223-025-01415-4.
2
Factors associated with impaired physical functionality in X-linked hypophosphatemia.
JBMR Plus. 2025 Feb 2;9(4):ziaf018. doi: 10.1093/jbmrpl/ziaf018. eCollection 2025 Apr.
3
Heart Failure and Osteoporosis: Shared Challenges in the Aging Population.
J Cardiovasc Dev Dis. 2025 Feb 13;12(2):69. doi: 10.3390/jcdd12020069.
4
Mapping the spatial atlas of the human bone tissue integrating spatial and single-cell transcriptomics.
Nucleic Acids Res. 2025 Jan 11;53(2). doi: 10.1093/nar/gkae1298.
5
The Lacunocanalicular Network is Denser in C57BL/6 Compared to BALB/c Mice.
Calcif Tissue Int. 2024 Nov;115(5):744-758. doi: 10.1007/s00223-024-01289-y. Epub 2024 Oct 16.
6
HIF-1α activation impairs dendrites formation and elongation in osteocytogenesis.
Heliyon. 2024 Jun 17;10(12):e32889. doi: 10.1016/j.heliyon.2024.e32889. eCollection 2024 Jun 30.
7
Alendronate treatment rescues the effects of compressive loading of TMJ in osteogenesis imperfecta mice.
Prog Orthod. 2024 Jul 15;25(1):25. doi: 10.1186/s40510-024-00526-2.
8
Osteocyte ferroptosis induced by ATF3/TFR1 contributes to cortical bone loss during ageing.
Cell Prolif. 2024 Oct;57(10):e13657. doi: 10.1111/cpr.13657. Epub 2024 May 19.
9
Ferroptosis in Osteocytes as a Target for Protection Against Postmenopausal Osteoporosis.
Adv Sci (Weinh). 2024 Mar;11(12):e2307388. doi: 10.1002/advs.202307388. Epub 2024 Jan 17.
10
Comparative study in estrogen-depleted mice identifies skeletal and osteocyte transcriptomic responses to abaloparatide and teriparatide.
JCI Insight. 2023 Oct 23;8(20):e161932. doi: 10.1172/jci.insight.161932.
本文引用的文献
1
Conditional deletion of IGF-I in osteocytes unexpectedly accelerates bony union of the fracture gap in mice.
Bone. 2016 Nov;92:18-28. doi: 10.1016/j.bone.2016.08.005. Epub 2016 Aug 9.
2
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
Kidney Int. 2016 Nov;90(5):985-996. doi: 10.1016/j.kint.2016.05.019. Epub 2016 Jul 22.
3
Identification of Senescent Cells in the Bone Microenvironment.
J Bone Miner Res. 2016 Nov;31(11):1920-1929. doi: 10.1002/jbmr.2892. Epub 2016 Oct 24.
4
Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to Exercise.
Cell Metab. 2016 Jun 14;23(6):1078-1092. doi: 10.1016/j.cmet.2016.05.004.
5
Osteocytic signalling pathways as therapeutic targets for bone fragility.
Nat Rev Endocrinol. 2016 Oct;12(10):593-605. doi: 10.1038/nrendo.2016.71. Epub 2016 May 27.
6
The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth.
Int J Biochem Cell Biol. 2016 Aug;77(Pt A):23-29. doi: 10.1016/j.biocel.2016.05.015. Epub 2016 May 19.
7
Systemic Control of Bone Homeostasis by FGF23 Signaling.
Curr Mol Biol Rep. 2016 Mar 1;2(1):62-71. doi: 10.1007/s40610-016-0035-5. Epub 2016 Feb 3.
8
Age and Outcomes Associated with BP in Patients with Incident CKD.
Clin J Am Soc Nephrol. 2016 May 6;11(5):821-831. doi: 10.2215/CJN.08660815. Epub 2016 Apr 21.
9
Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis.
Oncogene. 2016 Oct 27;35(43):5597-5607. doi: 10.1038/onc.2016.101. Epub 2016 Apr 4.
10
The Role of Osteocytes in Age-Related Bone Loss.
Curr Osteoporos Rep. 2016 Feb;14(1):16-25. doi: 10.1007/s11914-016-0297-0.
Zotero 插件